Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation

被引:74
作者
Bobadilla, Joseph L. [2 ]
Love, Robert B. [3 ]
Jankowska-Gan, Ewa [2 ]
Xu, Qingyong [2 ]
Haynes, Lynn D. [2 ]
Braun, Ruedi K. [3 ]
Hayney, Mary S. [6 ]
del Rio, Alejandro Munoz [2 ]
Meyer, Keith [5 ]
Greenspan, Daniel S. [4 ]
Torrealba, Jose [4 ]
Heidler, Kathleen M. [1 ]
Cummings, Oscar W. [7 ]
Iwata, Takekazu [8 ]
Brand, David [9 ]
Presson, Robert [10 ]
Burlingham, William J. [2 ]
Wilkes, David S. [1 ,3 ]
机构
[1] Indiana Univ, Sch Med, Ctr Immunobiol, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA
[2] Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Madison, WI USA
[3] Loyola Univ, Dept Thorac Surg, Maywood, IL 60153 USA
[4] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI USA
[5] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA
[6] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA
[7] Indiana Univ, Sch Med, Dept Pathol, Indianapolis, IN 46202 USA
[8] Chiba Univ, Grad Sch Med, Dept Thorac Surg, Chiba, Japan
[9] Univ Tennessee, Med Ctr, Memphis, TN USA
[10] Indiana Univ, Sch Med, Dept Anesthesia, Indianapolis, IN 46202 USA
关键词
lung transplantation; primary graft dysfunction; collagen type V; autoimmunity; memory T cell;
D O I
10.1164/rccm.200612-1901OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: The pathogenesis of primary graft dysfunction (PGD), a serious complication of lung transplantation, is poorly understood. Human studies and rodent models have shown that Collagen type V (col[V]), stimulates IL-17-dependent cellular immunity after lung transplantation. Objectives: To determine whether patients with end-stage lung disease develop pretransplant col(V)-specific cellular immunity, and if so, the impact of this response on PGD. Methods: Trans-vivo delayed-type hypersensitivity (TV-DTH) assays were used to evaluate memory T-cell responses to col(V) in 55 patients awaiting lung transplantation. Pa-o2/Fi(o2) index data were used to assess PGD. Univariate risk factor analysis was performed to identify variables associated with PGD. Rats immunized with col(V) or irrelevant antigen underwent lung isografting to determine if prior anti-col(V) immunity triggers PGD in the absence of alloreactivity. Measurements and Main Results: We found that 58.8% (10/17) of patients with idiopathic pulmonary fibrosis, and 15.8% (6/38) of patients without idiopathic pulmonary fibrosis tested while on the wait list for a lung transplant were col(V) DTH positive. Col(V) re activity was CD4(+) T-cell and monocyte mediated, and dependent on IL-17, IL-1 beta, and tumor necrosis factor (TNF)-alpha. Pao(2)/Fio(2) indices were impaired significantly 6-72 hours after transplantation in col(V)-reactive versus nonreactive patients. Univariate risk factor analysis identified only preoperative TV-DTH to col(V) and ischemic time as predictors of PGD. Finally, in a rat lung isograft model, col(V) sensitization resulted in significantly lower Pa-o2/Fi(o2) increased local TNF-alpha and IL-1 beta production, and a moderate-to-severe bronchiolitis/vasculitis when compared with control isografts. Conclusions: The data suggest that activation of innate immunity by col(V)-specific Th-17 memory cells represents a novel pathway to PGD after lung transplantation..
引用
收藏
页码:660 / 668
页数:9
相关论文
共 46 条
[11]   Mouse strain and injection site are crucial for detecting linked suppression in transplant recipients by trans-vivo DTH assay [J].
Burlingham, W. J. ;
Jankowska-Gan, E. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (02) :466-470
[12]   IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants [J].
Burlingham, William J. ;
Love, Robert B. ;
Jankowska-Gan, Ewa ;
Haynes, Lynn D. ;
Xu, Qingyong ;
Bobadilla, Joseph L. ;
Meyer, Keith C. ;
Hayney, Mary S. ;
Braun, Ruedi K. ;
Greenspan, Daniel S. ;
Gopalakrishnan, Bagavathi ;
Cai, Junchao ;
Brand, David D. ;
Yoshida, Shigetoshi ;
Cummings, Oscar W. ;
Willkes, David S. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (11) :3498-3506
[13]  
Burlingham WJ, 2005, MEASURING IMMUNITY: BASIC BIOLOGY AND CLINICAL ASSESSMENT, P407, DOI 10.1016/B978-012455900-4/50297-X
[14]   Trans vivo analysis of human delayed-type hypersensitivity reactivity [J].
Carrodeguas, L ;
Orosz, CG ;
Waldman, WJ ;
Sedmak, DD ;
Adams, PW ;
VanBuskirk, AM .
HUMAN IMMUNOLOGY, 1999, 60 (08) :640-651
[15]   Primary graft dysfunction in lung transplantation [J].
Carter, Yvonne Marie ;
Davis, R. Duane .
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 27 (05) :501-507
[16]   Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation [J].
Christie, JD ;
Carby, M ;
Bag, R ;
Corris, P ;
Hertz, M ;
Weill, D .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (10) :1454-1459
[17]   Impact of primary graft failure on outcomes following lung transplantation [J].
Christie, JD ;
Sager, JS ;
Kimmel, SE ;
Ahya, VN ;
Gaughan, C ;
Blumenthal, NP ;
Kotloff, RM .
CHEST, 2005, 127 (01) :161-165
[18]   Clinical risk factors for primary graft failure following lung transplantation [J].
Christie, JD ;
Kotloff, RM ;
Pochettino, A ;
Arcasoy, SM ;
Rosengard, BR ;
Landis, JR ;
Kimmel, SE .
CHEST, 2003, 124 (04) :1232-1241
[19]   Primary graft failure following lung transplantation [J].
Christie, JD ;
Bavaria, JE ;
Palevsky, HI ;
Litzky, L ;
Blumenthal, NP ;
Kaiser, LR ;
Kotloff, RM .
CHEST, 1998, 114 (01) :51-60
[20]   Twenty-year experience of lung transplantation at a single center: Influence of recipient diagnosis on long-term survival [J].
de Perrot, M ;
Chaparro, C ;
McRae, K ;
Waddell, TK ;
Hadjiliadis, D ;
Singer, LG ;
Pierre, AF ;
Hutcheon, M ;
Keshavjee, S .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2004, 127 (05) :1493-1501